Development of cell adhesion molecule antagonists as therapeutics for asthma and COPD

Author： Vanderslice P.   Biediger R.J.   Woodside D.G.   Berens K.L.   Holland G.W.   Dixon R.A.F.  

Publisher： Elsevier

ISSN： 1094-5539

Source： Pulmonary Pharmacology & Therapeutics, Vol.17, Iss.1, 2004-02, pp. : 1-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Tachykinin receptor antagonists for asthma and COPD

By Rogers Duncan F  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 7, 2001-07 ,pp. : 1097-1121

Informa Healthcare

Access to resources Recommend Favorite

Dysregulation of the neural cell adhesion molecule and neuropsychiatric disorders

By Vawter M.P.  

European Journal of Pharmacology, Vol. 405, Iss. 1, 2000-09 ,pp. : 385-395

Elsevier

Access to resources Recommend Favorite

Inhibitors of vascular cell adhesion molecule-1 expression

By Schreiner Erwin P   Oberhauser Berndt   Foster Carolyn A  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 2, 2003-02 ,pp. : 149-166

Informa Healthcare

Access to resources Recommend Favorite

New dual-acting bronchodilator treatments for COPD, muscarinic antagonists and β2 agonists in combination or combined into a single molecule

By Norman Peter  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 12, 2013-12 ,pp. : 1569-1580

Informa Healthcare

Access to resources Recommend Favorite

Progress in COPD and asthma

By  

Inpharma, Vol. 1, Iss. 1318, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite